Aurora Cannabis (NASDAQ:ACB - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.11 by ($0.04), Zacks reports. Aurora Cannabis had a net margin of 0.42% and a return on equity of 0.59%.
Aurora Cannabis Trading Down 4.4%
NASDAQ ACB opened at $5.88 on Wednesday. The company has a current ratio of 3.30, a quick ratio of 1.60 and a debt-to-equity ratio of 0.07. Aurora Cannabis has a 1-year low of $3.42 and a 1-year high of $7.20. The firm's fifty day simple moving average is $5.04 and its 200-day simple moving average is $4.74. The company has a market capitalization of $330.51 million, a PE ratio of 117.62 and a beta of 1.82.
Institutional Trading of Aurora Cannabis
An institutional investor recently raised its position in Aurora Cannabis stock. Goldman Sachs Group Inc. lifted its holdings in Aurora Cannabis Inc. (NASDAQ:ACB - Free Report) by 4.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 743,903 shares of the company's stock after purchasing an additional 29,099 shares during the period. Goldman Sachs Group Inc. owned 1.32% of Aurora Cannabis worth $3,266,000 as of its most recent filing with the SEC. 47.63% of the stock is currently owned by hedge funds and other institutional investors.
Aurora Cannabis Company Profile
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
